| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on December 11, 2005
From the Division of Molecular Diagnostics (T.N.), Advanced Medical Research Center, and Division of Nephrology and Endocrinology (M.S.), Department of Medicine, Nihon University School of Medicine (N.K., M.S.), Tokyo, Japan; Departments of Basic Medical Research and Education (Y.T.) and Geriatric Medicine (T.M.), Ehime University Graduate School of Medicine, Ehime, Japan; Department of Geriatric Medicine (T.K., T.O.), Osaka University Graduate School of Medicine, Osaka, Japan; Department of Pediatrics (Y.M.), Asahikawa Medical College, Asahikawa, Japan; Department of Public Health (A.H.), Graduate School of Medicine, Chiba University, Chiba, Japan; Departments of Clinical Studies (M.Y.) and Genetics (N.T.), Radiation Effects Research Foundation; and the Department of Medical Science and Cardiorenal Medicine (N.H., S.U.), Yokohama City University Graduate School of Medicine, Yokohama City, Japan. * To whom correspondence should be addressed. E-mail: tnakayam{at}med.nihon-u.ac.jp.
Abstract--Inactivating mutations in the follicle-stimulating hormone receptor (FSHR) gene have been reported to cause hereditary hypergonadotropic ovarian failure. It has been found recently that the FSHR knockout mouse exhibits hypertension. The aim of the present study was to investigate the association between polymorphisms in the human FSHR gene and essential hypertension (EH) by using single nucleotide polymorphisms (SNPs). We selected 5 SNPs in the gene (rs1394205, rs2055571, rs11692782, rs1007541, and rs2268361) and performed 2 genetic case-control studies in different populations. A confirmative case-control study was performed using 1035 EH patients and 1058 age-matched controls. Transcriptional activities were measured with a luciferase assay system. The first case-control study found that the A allele of rs1394205 was significantly higher in EH females (P=0.010). In addition, in the confirmative case-control study, there was a significant difference for this SNP between female normotensive subjects (44.5%) and EH patients (50.7%) (P=0.043). Multiple logistic regression analysis in female subjects also revealed a significant association of subjects with the A allele of rs1394205 with EH (P=0.033), with the odds ratio calculated as 1.68 (95% CI: 1.04 to 2.73). Transcriptional activity of the A allele was 56±8% (mean±SD) of that observed for the G-type allele (P=0.001). Serum estradiol levels were significantly lower in patients with the A/A genotype than in patients without the A/A genotype (P=0.004). The SNP in the 5'-untranslated region of the FSHR gene affects levels of transcriptional activity and is a susceptibility mutation of EH in women.
Revised on January 4, 2006
Mutation of the Follicle-Stimulating Hormone Receptor Gene 5'-Untranslated Region Associated With Female Hypertension
Tomohiro Nakayama*;
This article has been cited by other articles:
![]() |
A. Ferlin, M. Pengo, R. Selice, L. Salmaso, A. Garolla, and C. Foresta Analysis of single nucleotide polymorphisms of FSH receptor gene suggests association with testicular cancer susceptibility Endocr. Relat. Cancer, June 1, 2008; 15(2): 429 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-a. B. Shih and D. T. O'Connor Hereditary Determinants of Human Hypertension: Strategies in the Setting of Genetic Complexity Hypertension, June 1, 2008; 51(6): 1456 - 1464. [Full Text] [PDF] |
||||
![]() |
M. Coylewright, J. F. Reckelhoff, and P. Ouyang Menopause and Hypertension: An Age-Old Debate Hypertension, April 1, 2008; 51(4): 952 - 959. [Full Text] [PDF] |
||||
![]() |
B. K. Rana, P. A. Insel, S. H. Payne, K. Abel, E. Beutler, M. G. Ziegler, N. J. Schork, and D. T. O'Connor Population-Based Sample Reveals Gene-Gender Interactions in Blood Pressure in White Americans Hypertension, January 1, 2007; 49(1): 96 - 106. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |